TranS1 Inc. to Participate in the Lazard Capital Markets 3rd Annual Medical Technology Snowbird Event

/ Source: GlobeNewswire

WILMINGTON, N.C., Feb. 14, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, will participate in the LCM 3rd Annual Medical Technology Snowbird Event on Thursday, February 24, 2011 at the Snowbird Ski and Summer Resort in Snowbird, UT.

The conference format consists of a full day of one-on-one meetings. The conference will not be webcast. Institutional investors that wish to request a meeting with TranS1 should contact Lazard Capital Markets.

About TranS1 Inc.

TranS1 is a medical device company focused on designing, developing and marketing products that implement its proprietary approach to treat degenerative conditions of the spine affecting the lower lumbar region. TranS1 currently markets the AxiaLIF family of products for single and multilevel lumbar fusion and the Vectre and Avatar posterior fixation systems. TranS1 was founded in May 2000 and is headquartered in Wilmington, North Carolina. For more information, visit .

CONTACT: Investors: TranS1 Inc. Joseph P. Slattery, 910-332-1700 Executive Vice-President and Chief Financial Officer Westwicke Partners Mark Klausner, 443-213-0501 trans1@westwicke.com